Published on 28 Jun 2023 on Simply Wall St. via Yahoo Finance
Despite Nautilus Biotechnology's Pullback, Insiders Still Gained US$167k
Insiders who bought Nautilus Biotechnology, Inc. (NASDAQ:NAUT) stock lover the last 12 months are probably not as affected by last week’s 29% loss. After taking the recent loss into consideration, the US$469k worth of stock they bought is now worth US$636k, indicating that their investment yielded a positive return.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Nautilus Biotechnology